Vimarsana
Biggest News Aggregation in the World

Luc Boblet News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Luc Boblet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Luc Boblet Today - Breaking & Trending Today

Egle Therapeutics SAS: Egle Therapeutics Appoints Pierre Legault as Chairman and Board Member - Vimarsana News

Egle Therapeutics SAS: Egle Therapeutics Appoints Pierre Legault as Chairman and Board Member

Published: May 5, 2022

Egle Therapeutics SAS (Egle), an emerging biotechnology company dedicated to developing novel immunotherapies for oncology and autoimmune diseases, is pleased to announce Pierre Legault as Chairman

Source: finanznachrichten.de
Related Topics:
Kostenloser WertpapierhandelEliane PiaggioAmolyt PharmaArtios PharmaPierre LegaultInstitut CurieShulakova Deborah CockerillProsidion LtdSyndax PharmaceuticalsUrovant SciencesSciad Communications LtdAegle TherapeuticsLuc BobletBicycle TherapeuticsEdmunds Darya Shulakova Deborah CockerillCommunications Ltd
Egle Therapeutics Raises 40 Million € Series a to Develop First-In-Class T-regulatory Cells Therapies Based On Treg-starvers - Vimarsana News

Egle Therapeutics Raises 40 Million € Series a to Develop First-In-Class T-regulatory Cells Therapies Based On Treg-starvers

Published: October 22, 2021

LSP and Bpifrance, through its InnoBio 2 Fund, co-led international investor syndicate Egle Therapeutics SAS (Egle), an emerging biotechnology company focused on developing First-In-Class immunotherapies

Source: finanznachrichten.de
Related Topics:
United StatesFrance GeneralNoord HollandMarie CurieVincent BrichardEliane PiaggioBpifrance InnobioSacha Mann TakedaKostenloser WertpapierhandelJacques Mizrahi BioqubePasteur MutualitInstitut CurieJean Francois Morin Bpifrance InnobioFelice Verduyn Van WeegenDementia FundEuropean Union Under HorizonPhilippe Monteyne FundBoehringer IngelheimEuropean Fund For Strategic InvestmentsTakeda Pharmaceutical CompanyBioqube Factory FundTakeda Ventures IncLoncode InstituteEuropean UnionLife Sciences